DexCom, Inc. (ETR:DC4)

Market Cap	21.97B
Revenue (ttm)	3.66B
Net Income (ttm)	486.63M
Shares Out	n/a
EPS (ttm)	1.22
PE Ratio	45.15
Forward PE	27.28
Dividend	n/a
Ex-Dividend Date	n/a

Volume	135
Average Volume	320
Open	58.69
Previous Close	58.69
Day's Range	56.05 - 58.69
52-Week Range	51.62 - 88.54
Beta	n/a
RSI	36.87
Earnings Date	Oct 23, 2025

About DexCom

DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for the management of diabetes and metabolic health by patients, caregivers, and clinicians. Its products include Dexcom G6 and Dexcom G7, integrated CGM systems for diabetes management; Dexcom Share, a remote monitoring system; Dexcom Real-Time API, which enables authorized third-party software developers to integrate real-time...

• Industry: Electromedical and Electrotherapeutic Apparatus
• Founded: 1999
• Employees: 10,300
• Stock Exchange: Deutsche Börse Xetra
• Ticker Symbol: DC4

Financial Performance

In 2024, DexCom's revenue was $4.03 billion, an increase of 11.34% compared to the previous year's $3.62 billion. Earnings were $576.20 million, an increase of 6.41%.

Financial numbers in USD